All Episodes

January 9, 2023 23 mins

Melisa Sigley and Monisha Prakash, Medical Science Liaisons from AstraZeneca, join us to talk about a long-acting monoclonal antibody for pre-exposure prophylaxis of COVID-19 for specific individuals, known as EVUSHELD™ (tixagevimab co-packaged with cilgavimab). Please click on the link below to refer to the EVUSHELD™ Fact Sheet for Healthcare Providers for up-to-date and further product information. For any medical information requests and access to other AstraZeneca resources, please contact Melisa Sigley or visit AZmedical.com. 

https://www.azpicentral.com/pi.html?product=evusheld_hcp_fact

Mark as Played

Advertise With Us

Popular Podcasts

On Purpose with Jay Shetty

On Purpose with Jay Shetty

I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!

The Joe Rogan Experience

The Joe Rogan Experience

The official podcast of comedian Joe Rogan.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.